News from Portfolio Companies

New Ventures News and Publications

  • Barrett Rollins and The Reality of Precision Medicine
    For nearly a decade, the idea of “Precision Medicine” or similar variations like “Personalized Medicine” has been touted as the penultimate achievement of the Human Genome Project. Conceptually, this makes sense: once we figured out the DNA sequence, it stood to reason that we would be able to find the mutations that cause disease and develop therapeutics targeted to those ...
  • Barrett Rollins and the DNA-driven Transformation of Oncology
    EPISODE SUMMARY: Harry’s guest for this episode is Dr. Barrett Rollins, the chief scientific officer and faculty dean for academic affairs at Boston’s Dana Farber Cancer Institute and the Linde Family Professor of Medicine at Harvard Medical School. Harry and Dr. Rollins dig into how large-scale DNA analysis can one day put much more usable information into the hands of ...
  • Robert Green on the Impact of Individual Genomic Data
    Episode Summary: Harry’s guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women’s Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact of genomics on ...
  • How will AI/ML Driven Image Analytics change the future of Neuroimaging?
    Episode Summary: Harry talks with Wim Van Hecke, the founder and CEO of Icometrix—builder of a cloud-based AI platform for analyzing brain MRI and CT scans—to find out how the startup’s FDA-cleared technology is changing the way radiologists and other physicians interpret neuroimaging data. About Harry: Harry Glorikian is an influential global business expert with more than three decades of ...
  • Joel Dudley and What Happens When You Let Data–Not Hypotheses–Drive Discovery
    Episode Summary: Harry’s guest this week is Dr. Joel Dudley from the Icahn School of Medicine at Mount Sinai, where he serves as executive vice president of precision health, associate professor of genetics and genomic sciences, and founding director of the Institute for Next Generation Healthcare. Dr. Dudley explains how his group is utilizing data to uncover health problems that ...
  • Dr. Robert Green on Integrating Technology with Genomic Medicine to Move Healthcare Forward
    The idea behind Precision Medicine (PM), or its precursor, Personalized Medicine, has been tossed around the healthcare field for more than a decade now [1,2]. Whether it’s called PM, P4 medicine (Predictive, Preventive, Personalized, Participatory) [3], or systems medicine [4], it’s not dramatically different from how physicians have been treating patients for centuries—focusing on the patient and their specific problem ...
  • Sharon Terry on Changes in Drug Discovery, Diagnostics, and the Treatment of Patients
    Harry talks with Sharon Terry, president and CEO of Genetic Alliance, about the way drug discovery, diagnostics, and the treatment of patients are changing. Harry is well known for achievements in life sciences, healthcare, diagnostics, healthcare IT and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and ...
  • Every Patient in a Clinical Trial: How AI Can Solve One of Healthcare’s Biggest (and Most Expensive) Problems
    Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we ...
  • Can AI Prevent Failure in Drug Discovery Pipelines?
    Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we ...
  • To Reimagine Drug Discovery & Development, Let the Data Drive the Process
    Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we ...